GGrantIndex
Sort

15,842 grants matching pancreatic cancer

BIOMOLECULAR ANALYSIS USING LIQUID CRYSTALS

$399,019
Nicholas L Abbott · University Of Wisconsin-Madison · R01 · FY2011 · CA

Research Testbed 1

$398,992
Paolo Provenzano · University Of Minnesota · U54 · FY2023 · CA

Exploiting gold nanoparticle as a probe to identify therapeutic targets

$398,989
Priyabrata Mukherjee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2022 · CA

Project 1: Elucidating the genetics and cell of origin of pancreatic cancer initiation

$398,988
Laura D Attardi · Stanford University · P01 · FY2022 · CA

Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticles

$398,930
Lily Yang · Emory University · R01 · FY2019 · CA

Development of Muc1 Vaccine for the Prevention of Pancreatic Cancer

$398,919
Terisa Davis · · N03 · FY2013 · CA

TBEL Project 3

$398,880
Laura Delong Wood · University Of Tx Md Anderson Can Ctr · U54 · FY2022 · CA

Regulation of KRAS plasma membrane targeting by defined glycosphingolipids.

$398,862
John F Hancock · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · GM

Highly stable mini-circRNA vaccine with maximally activated and long-lasting T cells for HPV-related cancer combination immunotherapy

$398,823
Gordon Parry · Ampedrna Biosciences Llc · R43 · FY2024 · CA

Project 1 – IL-6/STAT3/NF-kB in Adipose-Muscle Crosstalk in the Pancreatic Cancer Macroenvironment

$398,795
Teresa A Zimmers · Medical University Of South Carolina · P01 · FY2021 · CA

Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer

$398,775
Scott Andrew Gerber · University Of Rochester · R01 · FY2019 · CA

Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism

$398,769
Deepak Nagrath · University Of Michigan At Ann Arbor · R01 · FY2021 · CA

A novel monobody-drug conjugate to treat mutant KRas pancreatic cancer.

$398,715
Craig Patrick Ramirez · Tezcat Laboratories Llc · R41 · FY2021 · CA

SBIR PHASE I TOPIC 406 - A PROTOTYPE SOLUTION TO FACILITATE PATIENT NAVIGATIONIN SUPPORT OF PANCREATIC CANCER CARE.

$398,711
Greg Downing · Gmg Arcdata Llc · N43 · FY2020 · CA

Vitamin B6 Modulates NK Cell Metabolism in Pancreatic Cancer

$398,591
Kamiya Mehla · University Of Oklahoma Hlth Sciences Ctr · R37 · FY2023 · CA

Regulation of exocrine pancreas formation

$398,576
Lori Sussel · Columbia University Health Sciences · R01 · FY2010 · DK

Optimizing the Treatment of Pancreatic Adenocarcinoma

$398,519
Chin Hur · Massachusetts General Hospital · R01 · FY2017 · CA

Histopathologic validation of 89Zr-DFO-HuMab-5B1 PET/CT imaging in CA 19-9 positive pancreatic cancer

$398,509
Neeta Pandit Taskar · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA

Cancer invasion: reciprocity between the extracellular matrix and intrinsic ERK signaling

$398,408
Michelle Christine Mendoza · University Of Utah · R01 · FY2022 · CA

Development of a Novel Resolvin-Based Therapy for Treatment of Pancreatic Cancer

$398,404
John Parkinson · Thetis Pharmaceuticals, Llc · R44 · FY2023 · CA

Discovery of Natural Products and Natural Product Derivatives as Inhibitors of KLK6 to Prevent the Progression of Preneoplastic Ductal Pancreatic Cancer

$398,398
John Edward Moses · Cold Spring Harbor Laboratory · UG3 · FY2025 · CA

Clinical trial development in cancer vaccines

$398,219
Samir Khleif · Basic Sciences · Z01 · FY2007 · CA

ALLOGENIC PANCREATIC TUMOR VACCINE CELL LINE

$398,129
Johns Hopkins University · R01 · FY2003 · CA

Role of extracellular matrix proteins and tumor stroma in DNA repair and cancer progression

$397,911
Taru Eliisa Muranen · Beth Israel Deaconess Medical Center · R01 · FY2021 · CA

Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer

$397,862
Kenneth P Olive · Columbia University Health Sciences · R01 · FY2023 · CA